“Prostate Cancer Today” — patient education meeting in Virginia Beach

This is reminder that Prostate Cancer International will be holding its second annual prostate cancer patient meeting (“Prostate Cancer Today: Living Well; Choosing Wisely”) on October 13, 2018, in Virginia Beach, near Norfolk, Virginia, USA. … READ MORE …

InfoLink hiatus for a week

Your sitemaster is going to be “off the grid” for the next week and therefore will not be posting news or addressing other items before Monday 23 July at the earliest. Hopefully, nothing too significant will happen while he is away.

Risk for DVT and PE as a complication of treatment with ADT

A newly published paper in Prostate Cancer and Prostatic Diseases has confirmed that there is an association between specific forms of androgen deprivation therapy (ADT) and certain types of adverse thromboembolic events. … READ MORE …

FDA approves use of enzalutamide (Xtandi) for nmCRPC

As we predicted just a couple of weeks ago, on Friday the US Food and Drug Administration (FDA) approved the use of enzalutamide (Xtandi) for the treatment of non-metastatic, castration-resistant prostate cancer (nmCRPC), … READ MORE …

New survey on sexual distress and prostate cancer

A new survey being conducted by an experienced research team at the University of Calgary in Canada is seeking participants. … READ MORE …

“The best” therapy for Gleason 10 prostate cancer

We recently saw (see this link) that men diagnosed with a Gleason score (GS) of 9 or 10 had lower rates of metastasis and better prostate-cancer survival if … READ MORE …

VPCa gets new web site on line

The organization known as Veterans Prostate Cancer Awareness (VPCa) was initially founded by Mike (“Bing”) Crosby back in 2016. … READ MORE …